# Profound Medical (PROF) — Earnings

PROF · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prof/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.26 |
| EPS estimate | −$0.24 |
| EPS surprise | −7.22% |
| Revenue surprise | −47.73% |
| Revenue | $2.5M |
| Revenue estimate | $4.8M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1628808/000110465926092066/prof-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/448f6d58-437e-917a-f069-efe58df8bb93.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.24 | −$0.26 | -7.22% | $4.8M | $2.5M |
| Q1 2026 | May 7, 2026 | −$0.25 | −$0.19 | 24.00% | $4.9M | $5.3M |
| Q4 2025 | Mar 5, 2026 | −$0.27 | −$0.27 | 1.21% | $7.7M | $6.0M |
| Q3 2025 | Nov 13, 2025 | −$0.37 | −$0.26 | 30.11% | $5.0M | $5.3M |
| Q2 2025 | Aug 14, 2025 | −$0.37 | −$0.52 | -40.54% | $3.3M | $2.2M |
| Q1 2025 | May 8, 2025 | −$0.28 | −$0.36 | -27.43% | $3.3M | $2.6M |
| Q4 2024 | Mar 7, 2025 | −$0.32 | −$0.20 | 37.98% | $4.2M | $4.2M |
| Q3 2024 | Nov 7, 2024 | −$0.30 | −$0.38 | -26.67% | $3.0M | $2.8M |
| Q2 2024 | Aug 8, 2024 | −$0.28 | −$0.28 | 0.60% | $2.6M | $2.2M |
| Q1 2024 | May 9, 2024 | −$0.30 | −$0.26 | 12.61% | $2.4M | $1.9M |
| Q4 2023 | Mar 7, 2024 | −$0.31 | −$0.42 | -34.44% | $2.0M | $2.0M |
| Q3 2023 | Nov 2, 2023 | −$0.34 | −$0.26 | 23.21% | $2.2M | $1.7M |
| Q2 2023 | Aug 9, 2023 | −$0.35 | −$0.35 | 0.37% | $2.1M | $1.6M |
| Q1 2023 | May 10, 2023 | −$0.35 | −$0.32 | 9.43% | $2.1M | $1.9M |
| Q4 2022 | Mar 7, 2023 | −$0.37 | −$0.46 | -23.39% | $2.7M | $1.3M |
| Q3 2022 | Nov 3, 2022 | −$0.38 | −$0.24 | 36.68% | $2.4M | $2.0M |
| Q2 2022 | Aug 4, 2022 | −$0.40 | −$0.28 | 29.35% | $2.0M | $2.0M |
| Q1 2022 | May 9, 2022 | −$0.45 | −$0.40 | 10.61% | $1.8M | $1.4M |
| Q4 2021 | Mar 3, 2022 | −$0.36 | −$0.49 | -38.03% | $2.8M | $1.0M |
| Q3 2021 | Nov 4, 2021 | −$0.29 | −$0.29 | 0.10% | $3.6M | $2.5M |

## Frequently Asked Questions

### When did Profound Medical (PROF) last report earnings?

Profound Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did PROF beat earnings estimates?

No. Profound Medical reported EPS of −$0.26 for Q2 2026 against a −$0.24 estimate — a 7.22% miss.

### How much revenue did PROF report last quarter?

Profound Medical reported $2.5M in revenue for Q2 2026, against a consensus estimate of $4.8M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).